Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure
he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E
284 Views
Q1FY26 Earnings Preview - Pharma and Healthcare
We anticipate that pharmaceutical companies within our coverage will collectively demonstrate revenue growth of 9.9% YoY and 0.8% QoQ, along with...
225 Views
Axis Top Picks for the month of July 2025
Our Top Picks Basket has delivered an impressive return of 336% since its inception (May’20), which stands well above the 175% return delivered by...
414 Views
APAC Healthcare Weekly (June 29)- RemeGen, Innovent, Daiichi, SanBio, Otsuka, Chugai, Glenmark
Last week couple of Chinese companies signed outlicensing deals with international players. Innovent got weight loss drug approval in China....
783 Views
Top Conviction Ideas - “Pharmaceutical & Hospitals” - Q4FY25 Pharma Review
The pharmaceutical universe under our coverage reported Q4FY25 growth of 12.3% YoY and 2.3% QoQ, driven by strong growth in the India business...
232 Views